Healthcare provider profile · identity verified

Jason Evans, MD

Family Practice · PERRYSBURG, OH · NPI 1205838802

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	265	81
Metoprolol Succinate	Metoprolol Succinate	251	66
Lisinopril	Lisinopril	243	67
Levothyroxine Sodium	Levothyroxine Sodium	220	54
Amlodipine Besylate	Amlodipine Besylate	218	53
Metformin Hcl Er	Metformin Hcl	194	55
Citalopram Hbr	Citalopram Hydrobromide	155	35
Omeprazole	Omeprazole	154	35
Simvastatin	Simvastatin	150	44
Meloxicam	Meloxicam	146	39
Losartan Potassium	Losartan Potassium	130	35
Lorazepam	Lorazepam	114	13
Alprazolam	Alprazolam	110	21
Glimepiride	Glimepiride	110	30
Trazodone Hcl	Trazodone Hcl	104	25
Hydrochlorothiazide	Hydrochlorothiazide	102	31
Metformin Hcl	Metformin Hcl	97	27
Tamsulosin Hcl	Tamsulosin Hcl	96	26
Pravastatin Sodium	Pravastatin Sodium	88	24
Gabapentin	Gabapentin	82	19
Furosemide	Furosemide	80	26
Bupropion Xl	Bupropion Hcl	74	13
Pantoprazole Sodium	Pantoprazole Sodium	73	20
Januvia	Sitagliptin Phosphate	69	13
Duloxetine Hcl	Duloxetine Hcl	64	13
Fluticasone Propionate	Fluticasone Propionate	64	26
Montelukast Sodium	Montelukast Sodium	59	16
Naproxen	Naproxen	56	18
Allopurinol	Allopurinol	55	13
Finasteride	Finasteride	55	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	53	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	52	26
Clopidogrel	Clopidogrel Bisulfate	52	15
Zolpidem Tartrate	Zolpidem Tartrate	52	13
Atenolol	Atenolol	51	11
Sertraline Hcl	Sertraline Hcl	51	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	48	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	48	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	11
Tizanidine Hcl	Tizanidine Hcl	45	15
Carvedilol	Carvedilol	42	12
Famotidine	Famotidine	42	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	42	35
Oxycodone Hcl	Oxycodone Hcl	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	suppressed
Donepezil Hcl	Donepezil Hcl	39	suppressed
Potassium Chloride	Potassium Chloride	39	12
Fentanyl	Fentanyl	37	suppressed
Synthroid	Levothyroxine Sodium	35	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	34	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Spironolactone	Spironolactone	34	12
Tramadol Hcl	Tramadol Hcl	34	12
Trulicity	Dulaglutide	34	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	suppressed
Pregabalin	Pregabalin	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Raloxifene Hcl	Raloxifene Hcl	31	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	30	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Morphine Sulfate Er	Morphine Sulfate	27	suppressed
Eliquis	Apixaban	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	24	11
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Prednisone	Prednisone	22	19
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	suppressed
Mometasone Furoate	Mometasone Furoate	21	16
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	13
Valacyclovir	Valacyclovir Hcl	18	suppressed
Jardiance	Empagliflozin	17	suppressed
Methylphenidate Er	Methylphenidate Hcl	17	suppressed
Ozempic	Semaglutide	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Klor-Con M10	Potassium Chloride	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Testosterone	Testosterone	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Torsemide	Torsemide	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Metolazone	Metolazone	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Bromocriptine Mesylate	Bromocriptine Mesylate	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Farxiga	Dapagliflozin Propanediol	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Valsartan	Valsartan	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Etodolac	Etodolac	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Ramipril	Ramipril	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error